AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates mitochondrial activity and protects human neurons from mitochondrial toxins

• Published in: Scientific reports 2023-05, Vol.13 (1), p.8334-8334, Article 8334
• Main Authors: Shi, Gongyu, Scott, Helen, Azhar, Nur Izzah Farhana Mohamad, Gialeli, Andriana, Clennell, Benjamin, Lee, Keng Siang, Hurcombe, Jenny, Whitcomb, Daniel, Coward, Richard, Wong, Liang-Fong, Cordero-Llana, Oscar, Uney, James B.
• Format: Article
• Language: English
• Subjects: 631/378; 631/378/1689; 631/378/1934; Alzheimer's disease; Amyotrophic lateral sclerosis; Apoptosis; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell death; Cyclin-dependent kinase; Cyclin-Dependent Kinases; Drug dosages; Glycolysis; Humanities and Social Sciences; Humans; Imidazoles; Inhibitors; Kinases; Membrane permeability; Mesencephalon; Mitochondria; Mitochondrial DNA; Mitochondrial permeability transition pore; Morphology; multidisciplinary; Neurons; Permeability; Phosphorylation; Protein Kinase Inhibitors; Rotenone; Science; Science (multidisciplinary); Toxins
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-35480-2

We previously reported that kenpaullone, which inhibits GSK-3a/b and CDKs inhibited CCCP mediated mitochondrial depolarisation and augments the mitochondrial network. To investigate the actions of this class of drug further, we compared the ability of kenpaullone, alsterpaullone, 1-azakenapaullone, AZD5438, AT7519 (CDK and GSK-3a/b inhibitors) and dexpramipexole and olesoxime (mitochondrial permeability transition pore inhibitors) to prevent CCCP mediated mitochondrial depolarisation and found that AZD5438 and AT7519, were the most effective. Furthermore, treatment with AZD5438 alone increased the complexity of the mitochondrial network. We also found that AZD5438 prevented the rotenone induced decrease in PGC-1alpha and TOM20 levels and that it mediated powerful anti-apoptotic effects and promoted glycolytic respiration. Importantly, experiments in human iPSC derived cortical and midbrain neurons showed AZD5438 mediated significant protective effects, preventing the neuronal cell death, and collapse in the neurite and mitochondrial network associated with rotenone treatment. These results suggest drugs that target GSK-3a/b and CDKs should be developed and assessed further as they may have significant therapeutic potential.